Domov › Ťažká depresívna porucha › New York
Klinické štúdie Ťažká depresívna porucha v štáte New York
48 štúdií pre Ťažká depresívna porucha hľadá účastníkov v zariadeniach v štáte New York.
Mestá v štáte New York
Oficiálny text štúdie (anglicky)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Adams Clinical Bronx, The Bronx
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Integrative Clinical Trials LLC, Brooklyn
- SPRI Clinical Trials, LLC, Brooklyn
- Bioscience Research LLC, Mount Kisco
- a 3 ďalších
Prebieha náborFáza 3
Vek 18 až 74 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Integrative Clinical Trials LLC, Brooklyn
- SPRI Clinical Trials, LLC, Brooklyn
- Bioscience Research LLC, Mount Kisco
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 až 74 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Ima Clinical Research - Nyc Midtown, New York
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07621237Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- SPRI Clinical Trials, LLC, Brooklyn
- Manhattan Behavioral Medicine, New York
Prebieha náborFáza 3
Vek 18 až 65 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Adams Clinical Harlem, New York
- New York State Psychiatric Institute, New York
- Davis Clinical (Adams Clinical Bronx), The Bronx
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 až 85 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, New York
- Vanda Investigational Site, New York
- Vanda Investigational Site, Staten Island
Prebieha náborFáza 3
Vek 18 až 65 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06830044DBS for TRD With the Medtronic Percept PC
- Icahn School of Medicine at Mount Sinai, Mount Sinai West, New York
Prebieha nábor
Vek 25 až 70 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT05773755Pattern Separation in Major Depressive Disorder
- New York State Psychiatric Institute (NYSPI), New York
Prebieha náborFáza 1
Vek 18 až 50 · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07139834A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Brooklyn
- Seaport Investigator Site, Cedarhurst
- Seaport Investigator Site, New York
- a 1 ďalších
Prebieha náborFáza 2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Integrative Clinical Trials LLC, Brooklyn
Prebieha náborFáza 2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07284667A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Bioscience Research, LLC, Mount Kisco
- Fieve Clinical Research, Inc., New York
- IMA Clinical Research, New York
Prebieha náborFáza 3
Vek 18 až 74 · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, New York
- Draig Clinical Site, New York
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Mount Sinai Hospital, New York
Prebieha nábor
Vek 22 až 70 · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, New York
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT07300969NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, New York
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 8. 2026 · NCT06911112A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Adams Clinical Harlem, New York
Prebieha náborFáza 3
Vek 18 až 74 · Všetky pohlavia · Aktualizované 10. 8. 2026 · NCT07592689NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, New York
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 8. 2026 · NCT06963021A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Adams Clinical Harlem, New York
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 6. 8. 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Integrative Clinical Trials, Brooklyn
- Richmond Behavioral Associates, Staten Island
Prebieha náborFáza 3
Vek 18 až 74 · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Neurobehavioral Research, Inc., Cedarhurst
Prebieha náborFáza 2
Vek 18 až 64 · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Neurobehavioral Research, Inc, Cedarhurst
- IMA Clinical Research - NYC Midtown, New York
- IMA Clinical Research - NYC Uptown, New York
Prebieha náborFáza 2
Vek 18 až 64 · Všetky pohlavia · Aktualizované 27. 7. 2026 · NCT07115329A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Glen Oaks
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 7. 2026 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Cedarhurst
- Neurocrine Clinical Site, Mount Kisco
- Neurocrine Clinical Site, New York
- a 2 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 7. 2026 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Brooklyn
- Clinical Research Site, New York
- Clinical Research Site, New York
- a 2 ďalších
Prebieha náborFáza 3
Vek 18 až 65 · Všetky pohlavia · Aktualizované 24. 7. 2026 · NCT07484217Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
- NYU Langone Health, New York
Prebieha nábor
Vek 24 až 65 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT07111390A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Ima Clinical Research - Manhattan /ID# 278212, New York
- Manhattan Behavioral Medicine /ID# 277910, New York
Prebieha náborFáza 2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 15. 6. 2026 · NCT07276997tDCS: Sleep to Mood in Depression (S2M-D)
- NYU Langone Health, New York
Prebieha nábor
Vek 18 až 65 · Všetky pohlavia · Aktualizované 8. 6. 2026 · NCT07572526Triage Survey for Psychiatry Research Eligibility
- Adams Clinical, Harlem, New York
- Adams Clinical, Bronx, The Bronx
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 20. 5. 2026 · NCT05800925A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- The Medical Research Network, LLC, New York
Prebieha náborFáza 2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 11. 5. 2026 · NCT06524830Aβ Dynamics in LLMD
- NYU Langone Health, New York
- Nathan S. Kline Institute for Psychiatric Research, Orangeburg
Prebieha náborFáza 4
Vek 60 a viac · Všetky pohlavia · Aktualizované 6. 5. 2026 · NCT05004987Mindfulness-Based fMRI Neurofeedback for Depression
- Columbia University Irving Medical Center, New York
Prebieha nábor
Vek 13 až 18 · Všetky pohlavia · Aktualizované 29. 4. 2026 · NCT05617495Neutralizing Interleukin (IL)-6
- Icahn School of Medicine at Mount Sinai, New York
Prebieha náborFáza 2Vítaní zdravých dobrovoľníkov
Vek 18 až 70 · Všetky pohlavia · Aktualizované 29. 4. 2026 · NCT07493317Maintenance rTMS for Depression (Maitr-De)
- Weill Cornell Medicine, New York
Prebieha nábor
Vek 18 až 80 · Všetky pohlavia · Aktualizované 29. 4. 2026 · NCT06938841Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
- Weill Cornell Medicine, New York
Prebieha nábor
Vek 50 až 80 · Všetky pohlavia · Aktualizované 27. 3. 2026 · NCT05925322Biomarker-guided rTMS for Treatment Resistant Depression
- Weill Cornell Medicine, New York
Prebieha náborFáza 3
Vek 22 až 65 · Všetky pohlavia · Aktualizované 25. 2. 2026 · NCT04041479The Role of mGluR5 in CBT-I
- Stony Brook University: Dept of Psychiatry, Stony Brook
Prebieha náborFáza 4
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 2. 2026 · NCT07076342Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33
- NYU Langone Health, New York
- Nathan Kline Institute for Psychiatric Research, Orangeburg
Prebieha nábor
Vek 18 až 65 · Všetky pohlavia · Aktualizované 5. 2. 2026 · NCT05573074Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #105, Brooklyn
- Autobahn Site #134, Brooklyn
- Autobahn Site #104, Staten Island
Prebieha náborFáza 2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 20. 1. 2026 · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Mount Kisco
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 10. 2025 · NCT06786624Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.